PAR paradigm biopharmaceuticals limited..

The Phase III Primer!, page-5

  1. 10,391 Posts.
    lightbulb Created with Sketch. 1418
    The effect size recorded in 008 was so high to give SS despite the variability that would typically skew the overall result. The larger sample size in 012 will reduce the impact
    of the outlier patients and draw out the uplift against the placebo. The biggest uplift (effect size) has been seen at our new end points day 112 and 404 (previous 365). Read up on this detail before Thursday. Hence we're no longer using day 56 despite it showing significant separation in 005, 008 etc.
    Last edited by Denial: 27/07/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
34.5¢
Change
-0.010(2.82%)
Mkt cap ! $137.1M
Open High Low Value Volume
36.0¢ 36.0¢ 33.8¢ $249.3K 726.6K

Buyers (Bids)

No. Vol. Price($)
2 4558 34.0¢
 

Sellers (Offers)

Price($) Vol. No.
34.5¢ 8581 1
View Market Depth
Last trade - 16.10pm 01/08/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.